DOI: 10.1002/cctc.201500764
Communications
Imine Reductase-Catalyzed Intermolecular Reductive
Amination of Aldehydes and Ketones
[
a]
Philipp N. Scheller, Maike Lenz, Stephan C. Hammer, Bernhard Hauer, and Bettina M. Nestl*
Imine reductases (IREDs) have emerged as promising biocata-
lysts for the synthesis of chiral amines. In this study, the asym-
metric imine reductase-catalyzed intermolecular reductive ami-
nation with NADPH as the hydrogen source was investigated.
A highly chemo- and stereoselective imine reductase was ap-
plied for the reductive amination by using a panel of carbonyls
with different amine nucleophiles. Primary and secondary
amine products were generated in moderate to high yields
with high enantiomeric excess values. The formation of the
imine intermediate was studied between carbonyl substrates
and methylamine in aqueous solution in the pH range of 4.0
vents that favored reversible imine formation by shifting the
equilibrium towards the condensation product.
The application of biocatalysis is an important complement
to chemical catalysis for chiral amine synthesis in water. To
date, two main types of enzymes have been investigated for
the transformation of carbonyl groups into amines: Amino
acid dehydrogenases and w-transaminases. Amino acid dehy-
drogenases catalyze the amination of carbonyl compounds,
usually a-keto acids and a-keto esters with NADH as the hy-
[
8]
drogen source. Using existing amino acid dehydrogenase
scaffolds, the group of Bommarius successfully altered the sub-
strate specificity through several rounds of protein engineering
1
to 9.0 by H NMR spectroscopy. We further measured the kinet-
[
9,10]
ics of the reductive amination of benzaldehyde with methyl-
amine. This imine reductase-catalyzed approach constitutes
a powerful and direct method for the synthesis of valuable
amines under mild reaction conditions.
to create amine dehydrogenases.
However, the application
of amine dehydrogenases still suffers from a poor substrate
scope. In contrast, w-transaminases catalyze the transfer of
amino groups from co-substrates to carbonyl compounds to
form new chiral amines. These enzymes have proven to be
powerful catalysts and are frequently used in the synthesis of
[
11–13]
Chiral amines are an important class of organic compounds
that serve as key intermediates in the synthesis of a variety of
a broad range of chiral amines.
Challenges associated with
w-transaminases are the disfavored reaction equilibrium for re-
ductive aminations of ketones and inhibition by the formed
byproduct. Both w-transaminases and amine dehydrogenases
are inherently restricted to the transfer of ammonia as amine
[1]
biologically active molecules. The most straightforward strat-
egy for the generation of chiral amines comprises the forma-
tion of C=N bonds by the condensation of carbonyls and
amines, followed by reduction of the in situ formed imine. The
chemoselectivity of the reducing agent, however, is crucial, as
it should efficiently reduce the C=N bond while leaving the po-
tentially reducible carbonyl compound unaffected. Tremen-
dous efforts have been made in the areas of organometallic
catalysis, organocatalysis, and biocatalysis to develop efficient
chemo-, regio-, and enantioselective strategies for this pro-
[
14]
substrate and thus, do not offer access to pharmaceutically
important chiral secondary and tertiary amine building blocks.
In this light, imine reductases represent a promising alternative
and extension to reported biocatalysts.
Previously, imine reductases were investigated for the asym-
metric reduction of C=N bonds with NADPH as the hydride
[
15–24]
donor.
To date, both (R)- and (S)-selective reductases have
[
2,3]
cess.
In the last several decades, most work has focused on
been screened for the transformation of five-, six-, and seven-
membered cyclic imines, dihydroisoquinolines, b-carbolines,
and iminium ions. They were shown to possess high catalytic
activities and stereoselectivities. This makes them promising
biocatalysts for chiral amine synthesis. However, whereas intra-
molecular reductions with the use of imine reductases have
been reported, only a few intermolecular ones have been de-
veloped. Evidently, intermolecular processes would represent
an important advancement in this methodology. Recent work
showed that the (S)-selective imine reductase from Streptomy-
ces sp. GF3546 catalyzed the conversion of 4-phenyl-2-buta-
none with methylamine into the corresponding product with
the transition-metal-catalyzed asymmetric hydrogenation of
imines with particular attention paid to the reductive amina-
tion of carbonyl compounds with primary amines. Several re-
agents and combinations have been reported through the
years with modified borohydride reagents playing a predomi-
[
4]
nant role. Inspired by biological systems in nature that use
NAD(P)H, the Hantzsch ester was employed as a hydrogen
donor in combination with chiral phosphoric acids for the
enantioselective reductive amination of aliphatic ketones to
[5–7]
furnish amines with excellent enantioselectivities.
In most
cases, these reactions were performed in different organic sol-
[
24]
8
.8% conversion and 76%ee.
Furthermore, Codexis/Merck
[
a] P. N. Scheller, M. Lenz, Dr. S. C. Hammer, Prof. Dr. B. Hauer, Dr. B. M. Nestl
Institute of Technical Biochemistry
Universität Stuttgart
Allmandring 31, 70569 Stuttgart (Germany)
E-mail: bettina.nestl@itb.uni-stuttgart.de
have developed and patented an engineered opine dehydro-
genase from Arthrobacter sp. possessing imine reductase activi-
ty for the conversion of various ketone and amine substrates
into secondary and tertiary amines under industrially applica-
[
25]
ble conditions. Despite these preliminary works, biocatalytic
reductive aminations to afford chiral amines in high yields with
ChemCatChem 2015, 7, 3239 – 3242
3239
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim